Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000213988 | SCV000269238 | benign | not specified | 2015-08-06 | criteria provided, single submitter | clinical testing | p.Cys45Cys in exon 1A of LTBP4: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 0.7% (20/2846) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broa dinstitute.org; dbSNP rs185400394). |
Gene |
RCV000838341 | SCV000980207 | likely benign | not provided | 2018-06-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ce |
RCV000838341 | SCV001747224 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | LTBP4: BP4, BP7, BS2 |
Prevention |
RCV003917872 | SCV004734574 | benign | LTBP4-related condition | 2019-10-31 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |